Vigilance Technical Committee Members

The Pharmacovigilance Technical Committee (PVTC) has been established under Section 13 of TMDA Act, Cap 219 to provide recommendations to the Director General on pharmacovigilance related safety issues. The committee is responsible for providing recommendations to the Director General on pharmacovigilance activities including causality assessment of Adverse Drug Reaction and Adverse Events.

Composition of the Committee

The PVTC is composed of experts with knowledge and experience in at least any of the following fields: medicine, pharmacology, toxicology, epidemiology, biostatistics, public health, pharmacovigilance/regulatory specialists and other related fields. The PVTC meets once quarterly and the current members are as listed in the table below: -

S/NName Title SpecialityInstitution
1.Prof. Kennedy MwambeteChairpersonPharmaceutical MicrobiologyMuhimbili University of Health and Allied Sciences (MUHAS)
2.Dr. Yonah HebronMemberRegulatory SciencesTanzania Medicines & Medical Devices Authority (TMDA)
3. Prof. Omary MinziMemberClinical PharmacyMuhimbili University of Health and Allied Sciences (MUHAS)
4. Dr. Anna KajiruMemberPharmacistImmunization And Vaccine Development Program (IVD)
5. Pharm. Anna David MwasomoloMemberPharmacistNational Malaria Control Programme (NMCP)
6. Mr. Saulo SarungiMemberPharmacistNational AIDS, STI and Hepatitis Control Programme (NASHCoP)
7. Dr. Amina MugunyaMemberInternal MedicineMuhimbili National Hospital (MNH)
8. Pharm. Chrispin NamkingaMemberPharmacistNational Tuberculosis and Leprosy Programme (NTLP)
9. Dr. Florence Salvatory KalabamuMemberPaediatrics and Child HealthHubert Kairuki Memorial University (HKMU)